Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Cholesterol-lowering Statins May Make Radiation More Effective at Treating Prostate Cancer

By HospiMedica staff writers
Posted on 19 Nov 2007
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs typically used to lower cholesterol have a 10% higher chance of being cured of their cancer at 10 years after diagnosis (76%), compared to those who do not take these medications (66%), according to a new study.

The study demonstrated that the greatest benefit of statin medications was observed in patients who had more aggressive or advanced forms of prostate cancer. More...
The study also demonstrated that men who took statins during high-dose radiation therapy had a lower rate of the cancer spreading to distant parts of the body.

"We were, indeed, surprised by the findings that statins used by these patients for other conditions was shown to improve the effectiveness of radiation treatment in killing prostate cancer cells,” said Michael J. Zelefsky, M.D., the senior author of the study and a radiation oncologist at Memorial Sloan-Kettering Cancer Center (New York, NY, USA). "The use of statins during radiation may also be effective in the treatment of other types of cancer. However, more studies are necessary to explore the association between statins and radiation treatment in curing cancers.”

The retrospective study involved nearly 900 men treated with high-dose radiation therapy for prostate cancer, some of whom were also taking statin drugs, from January 1995 to July 2000. Statins are a class of drugs used to lower the cholesterol level in individuals with or at risk of cardiovascular disease.

The study was presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th annual meeting held in Los Angeles, CA, USA.


Related Links:
Memorial Sloan-Kettering Cancer Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
New
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.